The in the treatment of vertebral compression fractures

LOR VERSION
The next generation in the treatment
of vertebral compression fractures
Limitations of Current Generation of Products
Products currently used to treat vertebral compression fractures
(VCF’s), although used by many treating doctors, are not without
limitations. They typically involve a bipedicular approach, involve a
large cavity and/or a low viscosity cement.
More invasive, bipedicular approach
Potentially compromising valuable bone
Current generation products involve
bipedicular needle placement,
potentially leading to more tissue
trauma than a unipedicular approach.
Balloon kyphoplasty may create
oversized cavities, potentially causing
unnecessary cancellous bone destruction
and compromising long-term vertebral
body stability.
Limited interdigitation
Uncontrolled cement delivery
Oversized cavities with low viscosity
cement may potentially prevent cement
interdigitation.
Many products involve a low viscosity
bone cement that may result in a greater
risk of extravasation.
Radiation exposure
Most products require physicians to
deliver cement near the radiation source.
The next generation in the treatment
of vertebral compression fractures
Cavity Creation
Designed for
Unipedular Access
DFine StabiliT ®
Navigational
Osteotome for
Site & Size Specific
Cavity
Extended
Working Time**
Distance from
Radiation Source
Yes
Yes
Yes
10 ft.
Medtronic Kyphx
No
No
No
0 ft.*
Stryker iVas
No
No
No
1.5 ft.
Carefusion AVAmax
No
No
No
1.5 ft.
DePuy Confidence
No
No
No
2.3 ft.
** When using a Bone Filler Device.
** Defined as ≥ 20 minutes at ≥ 20°C (data on file).
RF Targeted Vertebral Augmentation (RF-TVA™)
with the StabiliT® Vertebral Augmentation System
Unparalleled Control
Site and Size Specific Cavity Creation and Cement Delivery
The VertecoR ® MidLine Osteotome features an articulating tip that curls up to 90 degrees. This allows site and
size specific cavity creation via a unipedicular approach, potentially sparing valuable cancellous bone during the
cavity creation process, and facilitating site specific cement delivery.
VertecoR® MidLine
Osteotome
Unipedicular vertebral body access
Minimizes bone destruction
Creates a site and size specific cavity
Ultra High Viscosity Cement
StabiliT® ER2 Bone Cement is significantly more viscous than competitive bone cements, potentially decreasing
the risk of cement extravasation. StabiliT® ER2 Bone Cement also has an extended working time.
Viscosity (Pa*s)
6.000
5.000
StabiliT ® ER2
Ultra High
Viscosity Range
StabiliT® ER2 Bone Cement
(with energy)
4.000
3.000
2.000
1.000
7
12
17
22
Time (min)
27
32
37
Interdigitation and Distribution
Site and size specific cavity creation results in maintenance of cancellous bone into which StabiliT ® ER2 Bone Cement
can interdigitate.
Increased Safety
Reduced Physician Radiation Exposure
Using the Hand Switch Cable, physicians deliver cement at a controlled, constant rate
from up to ten feet from the radiation source.
10'
DFine
Physician executes delivery
up to 10 feet from patient side
Low Radiation Exposure
*
2.3'
DePuy
0'
Medtronic
Physician executes delivery
up to 2.3 feet from patient side
High Radiation Exposure
Physician executes delivery
at patient side
High Radiation Exposure
1.5'
Stryker
*When using a Bone Filler Device.
Physician executes delivery
up to 1.5 feet from patient side
High Radiation Exposure
Reduced Expense
StabiliT® ER2 Bone Cement’s extended working time often allows physicians to treat multiple levels with a single
fracture kit, resulting in hospital cost savings. Since the StabiliT ® System is available as a fully configured kit,
purchasing ancillary products is not required, thus reducing total procedure cost. Using the StabiliT® System
also results in reduced procedure time because it enables unipedicular vertebral body access.
NOISREV RO
Risks Statement
As with most surgical procedures, serious adverse events, some of which can be fatal, can occur. Although RF-TVA™
is designed to minimize these risks as much as possible, potential serious adverse events that can occur include:
• myocardial infarction (heart attack)
• cardiac arrest (heart stops beating)
• pulmonary embolism (cement leakage that migrates to the lungs)
• paralysis or muscle weakness
• cerebrovascular accident (stroke)
• death
A prescription is required. Please consult your physician for a discussion of these and other risks and if this
procedure is right for you.
Redefining the Treatment of Vertebral Pathologies
3047 Orchard Parkway, San Jose, CA 95134, USA • dfineinc.com • 866.96DFINE
©2010 DFine Inc. All rights reserved.
PML2754-AB (06-2011)